BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 34161952)

  • 21. Efficacy and safety of NAHAO® hydrogel in amelioration of chemoradiotherapy-induced oral mucositis: An preliminary clinical study (ChiCTR2200064766).
    Zhang Y; Mao R; Liu Z; Shi M; Song D; Liu X; Yan D; Bao J; Tang Y
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101568. PubMed ID: 37524129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Episil® in patients with hematologic malignancies: a comparative study.
    Fukutani T; Yoshioka Y; Imori S; Yanagihara H; Sumi K; Myoken Y; Fujita Y; Yanamoto S
    BMC Oral Health; 2024 May; 24(1):522. PubMed ID: 38698387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).
    Nishikawa K; Aoyama T; Oba MS; Yoshikawa T; Matsuda C; Munemoto Y; Takiguchi N; Tanabe K; Nagata N; Imano M; Oshiro M; Fukushima R; Kataoka M; Morita S; Tsuburaya A; Mishima H; Kono T; Sakamoto J
    J Cancer; 2018; 9(10):1725-1730. PubMed ID: 29805697
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel chitosan-based doxepin nano-formulation for chemotherapy-induced oral mucositis: a randomized, double-blinded, placebo-controlled clinical trial.
    Samiraninezhad N; Rezaee M; Gholami A; Amanati A; Mardani M
    Inflammopharmacology; 2023 Oct; 31(5):2411-2420. PubMed ID: 37668810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review.
    Nicol AJ; Ching JCF; Tam VCW; Liu KCK; Leung VWS; Cai J; Lee SWY
    Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Anxiety and Depression in Oral Mucositis Patients Undergoing Cancer Chemoradiotherapy: A Randomized Cross-sectional Study.
    Chaitanya NC; Garlapati K; Priyanka DR; Soma S; Suskandla U; Boinepally NH
    Indian J Palliat Care; 2016; 22(4):446-454. PubMed ID: 27803567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary intake effects on severity of cancer treatment-induced mucositis: A cross-sectional study.
    Manifar S; Tonkaboni A; Sobhanifar A; HafeziMotlagh K; Bitarafan S; Mazani M; Bossi P
    Health Sci Rep; 2023 Nov; 6(11):e1706. PubMed ID: 38028713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current trends in the management of oral mucositis related to cancer treatment.
    Biswal BM
    Malays J Med Sci; 2008 Jul; 15(3):4-13. PubMed ID: 22570584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal characterization of acute pain and toxicity kinetics during radiation therapy for head and neck cancer. A retrospective study.
    Salama V; Youssef S; Xu T; Wahid KA; Chen J; Rigert J; Lee A; Hutcheson KA; Gunn B; Phan J; Garden AS; Frank SJ; Morrison W; Reddy JP; Spiotto MT; Naser MA; Dede C; He R; Mohamed ASR; van Dijk LV; Lin R; Roldan CJ; Rosenthal DI; Fuller CD; Moreno AC;
    Oral Oncol Rep; 2023 Sep; 7():. PubMed ID: 38638130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
    Alsubaie HM; Alsini AY; Alsubaie KM; Abu-Zaid A; Alzahrani FR; Sayed S; Pathak AK; Alqahtani KH
    Head Neck; 2021 Oct; 43(10):3199-3213. PubMed ID: 34240498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy and applicability of natural products in the treatment and prevention of radiotherapy-induced oral mucositis: A systematic review.
    Zhang W; Fan L; Xie Y; Gao T; Zeng J
    PLoS One; 2024; 19(5):e0303988. PubMed ID: 38781255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of turmeric in the treatment of oral mucositis in patients with head and neck cancer after radiotherapy or chemoradiotherapy: a systematic review and meta-analysis.
    Wu CF; Wu HJ; Shih CL; Yeh TP; Ma WF
    Front Pharmacol; 2024; 15():1363202. PubMed ID: 38560351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plant-Derived Polyphenols to Prevent and Treat Oral Mucositis Induced by Chemo- and Radiotherapy in Head and Neck Cancers Management.
    Belfiore E; Di Prima G; Angellotti G; Panzarella V; De Caro V
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.
    Kunnumakkara AB; Hegde M; Parama D; Girisa S; Kumar A; Daimary UD; Garodia P; Yenisetti SC; Oommen OV; Aggarwal BB
    ACS Pharmacol Transl Sci; 2023 Apr; 6(4):447-518. PubMed ID: 37082752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of Under-Recognized Adjunctive Therapies for Cancer.
    Money ME; Matthews CM; Tan-Shalaby J
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant-Derived Substances with Antibacterial, Antioxidant, and Flavoring Potential to Formulate Oral Health Care Products.
    Lugo-Flores MA; Quintero-Cabello KP; Palafox-Rivera P; Silva-Espinoza BA; Cruz-Valenzuela MR; Ortega-Ramirez LA; Gonzalez-Aguilar GA; Ayala-Zavala JF
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized, Placebo-Controlled Study to Evaluate the Effect of Bio-Enhanced Turmeric Formulation on Radiation-Induced Oral Mucositis.
    Soni TP; Gupta AK; Sharma LM; Singhal H; Sharma S; Gothwal RS
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(2):103-113. PubMed ID: 34161952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients.
    Huang CJ; Huang MY; Fang PT; Chen F; Wang YT; Chen CH; Yuan SS; Huang CM; Luo KH; Chuang HY; Wang YY; Lee HH
    Am J Clin Nutr; 2019 Mar; 109(3):606-614. PubMed ID: 30753262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.